{"id":"W3205581928","doi":"10.1093/eurheartj/ehab706","title":"Ciraparantag as a potential universal anticoagulant reversal agent","year":2021,"lang":"en","type":"letter","venue":"European Heart Journal","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute","funders":"","keywords":"Medicine; Apixaban; Rivaroxaban; Dabigatran; Edoxaban; Idarucizumab; Warfarin; Anticoagulant; Atrial fibrillation; Stroke (engine); Intensive care medicine; Internal medicine","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001287272,0.0007857393,0.001014941,0.000635916,0.001025459,0.00235015,0.001172945,0.01270504,0.007133354],"category_scores_gemma":[0.005915655,0.0003315491,0.0008601074,0.000406163,0.001119916,0.002290922,0.000556948,0.01105378,0.007248974],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001550213,"about_ca_system_score_gemma":0.001251385,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000625637,"about_ca_topic_score_gemma":0.001412581,"domain_scores_codex":[0.9988179,0.0002347944,0.0001632807,0.0001523006,0.0005108641,0.0001208424],"domain_scores_gemma":[0.9980035,0.0008909702,0.0001729377,0.00004735945,0.0005138312,0.0003712508],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"not_applicable","study_design_gemma":"not_applicable","study_design_scores_codex":[0.00005786048,0.00002964294,0.0001768986,0.0001826843,0.00001046421,0.002766527,0.00002612748,0.00005454879,0.0002444782,0.001181126,0.9666531,0.0286164],"study_design_scores_gemma":[0.00006764937,0.00007848129,0.0003172266,0.0002459428,0.00001869922,0.006293788,0.0000296876,0.0001528518,0.0002031285,0.001175489,0.9914034,0.00001380665],"study_design_candidate":"not_applicable","study_design_consensus":"not_applicable","genre_codex":"commentary","genre_gemma":"commentary","genre_scores_codex":[0.001259245,0.04288715,0.0007020829,0.5491472,0.3851042,0.00006533472,0.0001083871,0.0001466447,0.02057981],"genre_scores_gemma":[0.007027862,0.02477823,0.0005850692,0.3697175,0.576169,0.00004769034,0.0001112024,0.00004764211,0.02151587],"genre_candidate":"commentary","genre_consensus":"commentary","teacher_disagreement_score":0.01270504,"threshold_uncertainty_score":0.02386349,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04126692935302673,"score_gpt":0.2865998430745937,"score_spread":0.245332913721567,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}